Science Prostate cancer
-
The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis
-
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study
-
Promoting integrated care in prostate cancer through online prostate cancer-specific holistic needs assessment: a feasibility study in primary care
-
The diagnostic value of miRNA-141 in prostate cancer: A systematic review and PRISMA-compliant meta-analysis
-
Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis
-
Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis
-
Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis
-
Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis
-
The primary treatment of prostate cancer with high-intensity focused ultrasound: A systematic review and meta-analysis
-
Effects of exercise interventions on social and cognitive functioning of men with prostate cancer: a meta-analysis
-
The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis
-
The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis
-
PSMA-targeted Radiotracers versus 18 F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis
-
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis
-
Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis
-
Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis
-
Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses
-
Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer
-
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
-
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
-
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
-
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
-
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
-
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
-
Prostate Cancer Nodal Staging: Using Deep Learning to Predict 68 Ga-PSMA-Positivity from CT Imaging Alone
-
The effect of information on prostate cancer screening decision process: a discrete choice experiment
-
Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials
-
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
-
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study
-
Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial
-
Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial
-
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
-
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
-
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
-
Olaparib for Metastatic Castration-Resistant Prostate Cancer
-
Patients’ education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer
-
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy